United States · 
Who invested in Evommune?
Evommune's investors include B Capital, RA Capital Management, RTW Investments LLC, EQT Life Sciences and Longwood Fund, and 1 more on record.
United States · Funded startup
Who invested in Evommune
Funding summaryUpdated 26 Oct 2026
$125Mraised across 1 round since 2026, from 1 source
- Latest round
- Round, $125MFeb 2026
- Investors
- 6
The rounds
- Feb 2026Round$125M
Source recorded
Founders and team
From Evommune's own website: 3 on the team.
- Luis PeñaPresident & Chief Executive Officer
- Felice Verduyn-van WeegenNon-Executive Director
- Let's CollaboratePartner with us to fight chronic inflammation.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Evommune as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Evommune
How much has Evommune raised?
Evommune has raised $125M across 1 round since 2026.
When did Evommune last raise?
Evommune's most recent round was an Undisclosed round of $125M in Feb 2026.
What was Evommune's biggest round?
Its most recent round, $125M in Feb 2026, is also its largest on record.
Who backed Evommune first?
Evommune's first round on record, in Feb 2026, was backed by B Capital, RA Capital Management and RTW Investments LLC and 3 others.
What stage is Evommune at?
Evommune's latest named round is an Undisclosed round, in Feb 2026.
Where is Evommune based?
Evommune is based in the United States.
Companies like Evommune
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.